Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Sarah Friedman, Kirtan Patel, Yan Liu, Sarah Hartzell & Michelle S. Keller. (2020) Urine Drug Testing among Opioid-Naïve and Long-Term Opioid Nevada Medicaid Beneficiaries. Substance Use & Misuse 55:14, pages 2314-2320.
Read now
Read now
Edward J. Cone, Anne Z. DePriest, Allan Gordon & Steven D. Passik. (2014) Risks and Responsibilities in Prescribing Opioids for Chronic Noncancer Pain, Part 2: Best Practices. Postgraduate Medicine 126:7, pages 129-138.
Read now
Read now
John H. Peniston. (2012) A Review of Pharmacotherapy for Chronic Low Back Pain with Considerations for Sports Medicine. The Physician and Sportsmedicine 40:4, pages 21-32.
Read now
Read now
Eugene R. Viscusi & Marco Pappagallo. (2012) A Review of Opioids for In-Hospital Pain Management. Hospital Practice 40:1, pages 149-159.
Read now
Read now
Robert L. Barkin, Stacy J. Barkin, Gordon A. Irving & Allan Gordon. (2011) Management of Chronic Noncancer Pain in Depressed Patients. Postgraduate Medicine 123:5, pages 143-154.
Read now
Read now
Irma H Benedek, Janet Jobes, Qinfang Xiang & William D Fiske. (2011) Bioequivalence of oxymorphone extended release and crush-resistant oxymorphone extended release. Drug Design, Development and Therapy 5, pages 455-463.
Read now
Read now
Roy D. Altman & Howard S. Smith. (2010) Opioid Therapy for Osteoarthritis and Chronic Low Back Pain. Postgraduate Medicine 122:6, pages 87-97.
Read now
Read now
Laxmaiah Manchikanti, Ramsin Benyamin, Sukdeb Datta, Ricardo Vallejo & Howard Smith. (2010) Opioids in chronic noncancer pain. Expert Review of Neurotherapeutics 10:5, pages 775-789.
Read now
Read now
Articles from other publishers (20)
Kenichi Tamama. (2021) Advances in drugs of abuse testing. Clinica Chimica Acta 514, pages 40-47.
Crossref
Crossref
Gwendolyn A. McMillin, Kamisha L. Johnson-Davis, Brian N. Kelly, Bonnie ScottYifei K. Yang. (2021) Impact of the Opioid Epidemic on Drug Testing. Therapeutic Drug Monitoring 43:1, pages 14-24.
Crossref
Crossref
Kenichi Tamama. 2021.
191
214
.
Anne Z. DePriest. 2020. Principles of Forensic Toxicology. Principles of Forensic Toxicology
77
89
.
Li Liu, Sarah E Wheeler, Raman Venkataramanan, Jacqueline A Rymer, Anthony F Pizon, Michael J Lynch & Kenichi Tamama. (2018) Newly Emerging Drugs of Abuse and Their Detection Methods. American Journal of Clinical Pathology 149:2, pages 105-116.
Crossref
Crossref
Jeffrey R Enders, Jeremy P Smith, Sheng Feng, Erin C Strickland & Gregory L McIntire. (2018) Analytical Considerations When Developing an LC-MS/MS Method for More than 30 Analytes. The Journal of Applied Laboratory Medicine 2:4, pages 543-554.
Crossref
Crossref
Naum Shaparin, Neel Mehta, Frank Kunkel, Richard Stripp, Damon Borg & Elizabeth Kolb. (2017) A Novel Chronic Opioid Monitoring Tool to Assess Prescription Drug Steady State Levels in Oral Fluid. Pain Medicine 18:11, pages 2162-2169.
Crossref
Crossref
Kamisha L. Johnson-Davis, Aaron J. Sadler & Jonathan R. Genzen. (2016) A Retrospective Analysis of Urine Drugs of Abuse Immunoassay True Positive Rates at a National Reference Laboratory. Journal of Analytical Toxicology 40:2, pages 97-107.
Crossref
Crossref
Judith A. Turner, Kathleen Saunders, Susan M. Shortreed, Suzanne E. Rapp, Stephen Thielke, Linda LeResche, Kim M. Riddell & Michael Von Korff. (2013) Chronic Opioid Therapy Risk Reduction Initiative: Impact on Urine Drug Testing Rates and Results. Journal of General Internal Medicine 29:2, pages 305-311.
Crossref
Crossref
Alain Vanasse, Mireille Courteau, Josiane Courteau & Nathalie Carrier. 2014. Mental Health and Pain. Mental Health and Pain
81
97
.
Serge Marchand, Djea Saravane & Isabelle GaumondA. Vanasse, M. Courteau, J. Courteau & N. Carrier. 2013. Santé mentale et douleur. Santé mentale et douleur
53
71
.
Michael C. Milone. (2012) Laboratory Testing for Prescription Opioids. Journal of Medical Toxicology 8:4, pages 408-416.
Crossref
Crossref
Joanna L. Starrels, Aaron D. Fox, Hillary V. Kunins & Chinazo O. Cunningham. (2012) They Don’t Know What They Don’t Know: Internal Medicine Residents’ Knowledge and Confidence in Urine Drug Test Interpretation for Patients with Chronic Pain. Journal of General Internal Medicine 27:11, pages 1521-1527.
Crossref
Crossref
Steven P. Stanos, Patricia Bruckenthal & Robert L. Barkin. (2012) Strategies to Reduce the Tampering and Subsequent Abuse of Long-acting Opioids: Potential Risks and Benefits of Formulations With Physical or Pharmacologic Deterrents to Tampering. Mayo Clinic Proceedings 87:7, pages 683-694.
Crossref
Crossref
William D. Fiske, Janet Jobes, Qinfang Xiang, Sou-Chan Chang & Irma H. Benedek. (2012) The Effects of Ethanol on the Bioavailability of Oxymorphone Extended-Release Tablets and Oxymorphone Crush-Resistant Extended-Release Tablets. The Journal of Pain 13:1, pages 90-99.
Crossref
Crossref
Gary F. Bouloux. (2011) Use of Opioids in Long-Term Management of Temporomandibular Joint Dysfunction. Journal of Oral and Maxillofacial Surgery 69:7, pages 1885-1891.
Crossref
Crossref
Judith A. Paice & Betty Ferrell. (2011) The management of cancer pain. CA: A Cancer Journal for Clinicians 61:3, pages 157-182.
Crossref
Crossref
Edward J. Cone & Yale H. Caplan. (2011) Re: Pergolizzi et al., 2010: The Role of Urine Drug Testing for Patients on Opioid Therapy. Pain Practice 11:3, pages 309-309.
Crossref
Crossref
Howard Smith & Patricia Bruckenthal. (2010) Implications of Opioid Analgesia for Medically Complicated Patients. Drugs & Aging 27:5, pages 417-433.
Crossref
Crossref
Edward J. Cone, Anne Zichterman, Rebecca Heltsley, David L. Black, Beverly Cawthon, Tim Robert, Frank Moser & Yale H. Caplan. (2010) Urine testing for norcodeine, norhydrocodone, and noroxycodone facilitates interpretation and reduces false negatives. Forensic Science International 198:1-3, pages 58-61.
Crossref
Crossref